Yan Li
University of Sydney(AU)Guiyang Medical University(CN)Bristol-Myers Squibb (Germany)(DE)Sun Yat-sen University(CN)Shenzhen University(CN)Shandong Normal University(CN)State Intellectual Property Office(CN)Ruijin Hospital(CN)Bristol-Myers Squibb (United States)(US)Sun Yat-sen Memorial Hospital(CN)Ningxia Medical University(CN)Shanghai Institute of Hypertension(CN)Bristol-Myers Squibb (Sweden)(SE)Ningxia Medical University General Hospital(CN)Tianjin Hospital(CN)Shenzhen University Health Science Center(CN)Central Hospital of Zibo(CN)State Key Laboratory of Medical Genomics
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Ubiquitin and proteasome pathways
Most-Cited Works
- → In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs(2012)212 cited
- → A bibliometric analysis of PROTAC from 2001 to 2021(2022)105 cited
- → Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development(2010)102 cited
- → Chemoselective Synthesis of Lenalidomide-Based PROTAC Library Using Alkylation Reaction(2019)73 cited
- → Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance(2020)73 cited
- → IL-6 receptor expression and IL-6 effects change during osteoblast differentiation(2008)73 cited